Overview
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process.
This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.
Eligibility
Inclusion Criteria:
- Age ≥ 50 years
- ASMI < 7 kg/m2 in men
- ASMI < 5.7 kg/m2 in women
- Grip strength < 28 kg in men
- Grip strength < 18 kg in women
- Walk speed < 1 m/s
Exclusion Criteria:
- People who are allergic to supplements
- cancer
- heart failure
- kidney disease
- autoimmune disease
- neurodegenerative disease